Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade D 5.32 -2.03% -0.11
AUPH closed down 2.03 percent on Friday, August 17, 2018, on 86 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AUPH trend table...

Date Alert Name Type % Chg
Aug 17 Downside 200 DMA Break Bearish 0.00%
Aug 16 200 DMA Support Bullish -2.03%
Aug 16 MACD Bullish Signal Line Cross Bullish -2.03%
Aug 15 Stochastic Buy Signal Bullish -2.21%
Aug 15 Upside 200 DMA Break Bullish -2.21%
Aug 15 Oversold Stochastic Weakness -2.21%
Aug 14 Oversold Stochastic Weakness 0.38%
Aug 13 200 DMA Resistance Bearish 0.76%
Aug 13 Stochastic Reached Oversold Weakness 0.76%
Aug 13 Oversold Stochastic Weakness 0.76%

Older signals for AUPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Is AUPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 4.41
Average Volume 411,268
200-Day Moving Average 5.4183
50-Day Moving Average 5.6126
20-Day Moving Average 5.4725
10-Day Moving Average 5.357
Average True Range 0.1918
ADX 14.57
+DI 22.497
-DI 17.5507
Chandelier Exit (Long, 3 ATRs ) 5.4046
Chandelier Exit (Short, 3 ATRs ) 5.7954
Upper Bollinger Band 5.872
Lower Bollinger Band 5.073
Percent B (%b) 0.31
BandWidth 14.600274
MACD Line -0.0858
MACD Signal Line -0.0869
MACD Histogram 0.0011
Fundamentals Value
Market Cap 444.14 Million
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -4.09
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.62
Resistance 3 (R3) 5.63 5.54 5.57
Resistance 2 (R2) 5.54 5.46 5.54 5.55
Resistance 1 (R1) 5.43 5.42 5.39 5.42 5.54
Pivot Point 5.34 5.34 5.32 5.34 5.34
Support 1 (S1) 5.23 5.26 5.19 5.22 5.10
Support 2 (S2) 5.14 5.22 5.14 5.09
Support 3 (S3) 5.03 5.14 5.07
Support 4 (S4) 5.02